Increasing Diabetic Population Key Driver for Blood Glucose Test Strips

A recently published report by Technavio reveals that the Global Blood Glucose Test Strips market is expected to grow at a CAGR of 8.7 percent over the period 2010–2014.

London, UK, September 23, 2011 -- A recently published report by Technavio, specialists in emerging technologies market research, reveals that the Global Blood Glucose Test Strips market is expected to grow at a CAGR of 8.7 percent over the period 2010–2014. The report, which covers the Americas as well as the EMEA and APAC regions, indicates that the market is being driven by the growing number of diabetic patients across regions.

According to Technavio’s industry analyst, “There is an increase in the number of diabetic patients across the world as a result of changing lifestyles and genetic predisposition. More than 25 percent of the US population suffers from diabetes. As a result, the demand for blood glucose diagnosis performed at hospitals, diagnostic centers, and at homes has seen a significant increase.”

The report also highlights that the presence of counterfeit products is hindering the growth of this market. However, the low price of these blood glucose test strips is expected to keep driving demand. This market is also marked by the increased adoption of diabetes management at home. These are just some of the important findings presented in the report that will enable companies to fully understand the potential in this market and formulate their own strategies.

Technavio’s report, Global Blood Glucose Test Strips Market 2010–2014, is based on extensive research conducted with industry experts, vendors, and end-users. It examines the key trends, drivers, and challenges impacting the evolution of this market. The report also contains incisive insights and SWOT analyses regarding the key vendors in this market.

Companies mentioned in this report include Hoffmann-La Roche, LifeScan, Abbott Diabetes Care, and Bayer Diabetes Care.

For further information and to obtain your copy of this report, please visit http://www.technavio.com/content/global-blood-glucose-test-strips-market-2010-2014.

Media Contact:
Ludmila Berkesova
Program Manager
Technavio
8 Wimpole Street
W1G 9SP London UK
Tel: 0044 207 637 2456
Fax: 0044 845 280 2825
Posted by No comments:

Global Carbon Nanotubes Market Witnessing Decline in Prices

A recently published report by Technavio reveals that the Global Carbon Nanotube market is expected to grow at a CAGR of 56.5 percent over the period 2010–2014.

London, UK, September 23, 2011 -- A recently published report by Technavio, specialists in emerging technologies market research, reveals that the Global Carbon Nanotube market is expected to grow at a CAGR of 56.5 percent over the period 2010–2014. The report, which covers the Asia Pacific region as well as the Americas and Europe, indicates that the market is being driven by the increased demand from the Aerospace and Defense industries.

According to Technavio’s industry analyst, “Being one of the strongest known materials, Carbon Nanotubes improve the strength of many materials used in various applications including Aerospace. In the area of Defense, Carbon Nanotube fibers are being used in the advancement of composite armor systems for vehicles and body armors. These applications in the Aerospace and Defense industry have had a positive impact on market growth.”

The report also highlights that the high production cost could hinder the growth of this market. However, the emergence of several research initiatives in this field is expected to boost market growth. This market is also marked by a substantial decline in prices of these tubes. These are just some of the important findings presented in the report that will enable companies to fully understand the potential in this market and formulate their own strategies.

Technavio’s report, Global Carbon Nanotube Market 2010–2014, is based on extensive research conducted with industry experts, vendors, and end-users. It examines the key trends, drivers, and challenges impacting the evolution of this market. The report also contains incisive insights and SWOT analyses regarding the key vendors in this market.

Companies mentioned in this report include Bayer MaterialScience AG, Nanocyl, CNano, and Arkema.

For further information and to obtain your copy of this report, please visit http://www.technavio.com/content/global-carbon-nanotube-market-2010-2014.

Media Contact:
Ludmila Berkesova
Program Manager
Technavio
8 Wimpole Street
W1G 9SP London UK
Tel: 0044 207 637 2456
Fax: 0044 845 280 2825
Posted by No comments:

Government Policies Encouraging Use of Bioplastics

A recently published report by Technavio reveals that the Global Bioplastics market is expected to grow at a CAGR of 32 percent over the period 2010-2014.

London, UK, September 23, 2011 -- A recently published report by Technavio, specialists in emerging technologies market research, reveals that the Global Bioplastics market is expected to grow at a CAGR of 32 percent over the period 2010-2014. The report, which covers the Americas as well as the EMEA and APAC regions, indicates that the market is being driven by the favorable policies adopted by various governments.

According to Technavio’s industry analyst, “The excess use of plastics has led to an increase in CO2 emission and toxic landfills. As a result, governments of various countries have been encouraging production of bioplastics. The US Government has introduced the Federal Farm Bill Energy title 9, which urges Federal Agencies to buy bioplastic items. Also, the Kyoto Protocol has been established where member countries have agreed to reduce CO2 emission by adopting various measures, including bioplastics.”

The report also highlights that the high cost of production is hindering the growth of this market. However, the rising costs of petroleum products are expected to drive the market. This market is also marked by the increased usage of bioplastics in the Automobile industry. These are just some of the important findings presented in the report that will enable companies to fully understand the potential in this market and formulate their own strategies.

Technavio’s report, Global Bioplastics Market 2010–2014, is based on extensive research conducted with industry experts, vendors, and end-users. It examines the key trends, drivers, and challenges impacting the evolution of this market. The report also contains incisive insights and SWOT analyses regarding the key vendors in this market.

Companies mentioned in this report include Natureworks LLC, Novamont SpA, ADM/Metabolix, Toyota Motor Corp., and BASF.

For further information and to obtain your copy of this report, please visit http://www.technavio.com/content/global-bioplastics-market-2010-2014.

Media Contact:
Ludmila Berkesova
Program Manager
Technavio
8 Wimpole Street
W1G 9SP London UK
Tel: 0044 207 637 2456
Fax: 0044 845 280 2825
Posted by No comments:

AAA reports on forestry bond support

Environmentalists are calling for the creation of more forestry bonds in order to help raise the cash needed to reduce deforestation by half by 2020, according to reports from Alternative Asset Analysis (AAA).

Boston, MA, USA, September 23, 2011 -- Alternative Asset Analysis (AAA) is supporting calls for the creation of more forestry bonds in order to help raise the cash needed to reduce deforestation by half by 2020.

According to organizations such as WWF, the Global Canopy Programme and the Climate Bonds Initiative, the creation of a greater number of forestry bonds, which would drive investment into the forestry sector, will help reduce climate change. They claim that $30 billion of investment each year will help to halve deforestation and safeguard the carbon absorption capabilities of the world's forested land.

Climate Bonds Initiative chairman, Sean Kidney, told BusinessGreen that providing the bonds offered have the potential to generate healthy returns, investors will flock to them: "If you offer investors an AA-rated forest bond or an AA-rated oil bond, most of them will take the green option. You have to remember that 19 of the 20 largest pension funds are public sector funds and they're concerned about climate," he said.

AAA is an analysis and advocacy group that backs alternative investments of all kinds, with a focus on ethical and environmentally sound options. It claims there are already several successful investment opportunities that drive cash towards forestry and increase the amount of forested land in their areas of operation.

Greenwood Management, for example, invites investors to buy up areas of land in Brazil that are planted with non-native trees for eventual use as charcoal in the local steel industry and for export. AAA claims that these kinds of projects help the Brazilian government to impose legislation that outlaws the logging of native trees.

The campaigners are calling for focus to be put on the creation of forestry bonds during the meeting of climate negotiators scheduled for the Durban climate talks in November. AAA’s analysis partner Anthony Johnson spoke out in support of the campaigners, saying, “Forestry bonds make perfect sense, particularly in the current economic climate where investors are desperately searching for alternative asset classes to diversity their investment portfolios.”

About Alternative Asset Analysis:
The remit of Alternative Asset Analysis is to analyse and provide news on the global performance of a wide range of alternative asset classes including, but not restricted to, commodities, real estate, forestry, foreign exchange, hedge funds, private equity and venture capital.

Contact:
Anthony Johnson
Alternative Asset Analysis
71 Commercial St
Boston, MA 02109-1320
617-939-9596
Posted by No comments:

IAPAM Links Medical Spa Growth to Demand for Physician Botox ® Training

The IAPAM has identified a correlation between the increase in physicians engaging in the IAPAM’s comprehensive, hands-on Botox ® Training, and the significant growth in botox ® and dermal filler procedures.

Las Vegas, NV, September 23, 2011 -- The market research group, Global Industry Analysts, projects that the 70 million baby boomers, "seeking to keep the dreaded signs of aging at bay," will significantly impact the US market for aesthetic anti-aging treatments, including Botox ® and dermal fillers. The market for these age defying products or treatments is currently estimated at $80 billion, and Global Industry Analysts predicts it will balloon to more than $114 billion by the year 2015. To capture this exploding market, physicians who are expertly trained in minimally invasive, anti-aging modalities and medical weight loss treatments, are best positioned to grow their healthcare businesses.

The IAPAM's Aesthetic Medicine Symposium (http://www.AestheticMedicineSymposium.com/botoxtraining.html) is a weekend of comprehensive Botox ® training as well as dermal filler training, laser training, medical grade chemical peel training, medical microdermabrasion training, and hCG training (http://www.hcgtraining.com), and is the only multi-day, hands-on symposium, to offer education for physicians on how to profitably add the top 5 anti-aging modalities to a practice.

Jeff Russell, Executive Director of the IAPAM, concurs with the findings of Global Industry Analysts' research. "We are hearing from our members that minimally invasive procedures like cosmetic injectables, medically supervised hCG for weight loss, as well as microdermabrasion and chemical peels are in tremendous demand by patients, and we are seeing a correlating increase in the demand for our training. Registration for our cornerstone training program, the IAPAM's Aesthetic Medicine Symposium (http://www.aestheticmedicinesymposium.com), has dramatically increased in the last 9 months. We have sold out every session in 2011. Physicians are realizing they not only need to offer botox ® treatments to their patients, but also laser hair removal, IPL skin rejuvenation, chemical peels, and microdermabrasion. Organizations, like the IAPAM, educate physicians on how to package these treatments for the most appealing and profitable outcomes."

The IAPAM's Aesthetic Medicine Symposium provides a forum for physicians to immerse themselves in training in the top 5 minimally invasive procedures. Leading the faculty is a team of renowned cosmetic dermatologists, who cover aesthetic patient consultations, facial anatomy & musculature, product preparation, pain management, procedural protocols, post treatment issues and continuing practice support. Unlike other programs, the IAPAM's Botox ® training is done in a clean, multi-million dollar medical facility, not a hotel room chair.

For more information on the next Aesthetic Medicine Symposium and/or the hCG/Physician Weight Loss Training, or to register (http://www.aestheticmedicinesymposium.com/registration) for a session, please see http://www.iapam.com or contact the IAPAM at 1-800-219-5108 ext. 704.

Botox, Botox Cosmetic and Juvederm are trademarks of Allergan, Inc. Dysport, Restylane, Perlane are trademarks of Medicis, Inc.

About the IAPAM: The International Association for Physicians in Aesthetic Medicine

The International Association for Physicians in Aesthetic Medicine is a voluntary association of physicians and supporters, which sets standards for the aesthetic medical profession. The goal of the association is to offer education, ethical standards, credentialing, and member benefits. IAPAM membership is open to all licensed medical doctors (MDs), dentists (DDSs/DMDs) doctors of osteopathic medicine (DOs), physicians assistants (PAs) and nurse practitioners (NPs). The IAPAM offers aesthetic medicine and hCG medical weight management programs, including: Botox ® training, medical aesthetic training, laser training, physician hCG training, and aesthetic practice business training. Additional information about the association can be accessed through the IAPAM’s website (http://www.iapam.com) or by contacting:

Jeff Russell, Executive-Director
International Association for Physicians in Aesthetic Medicine (IAPAM)
1-800-219-5108 x704
Posted by No comments:
Subscribe to: Posts (Atom)